HEADER HYDROLASE/HYDROLASE INHIBITOR 12-AUG-05 2AOJ TITLE CRYSTAL STRUCTURE ANALYSIS OF HIV-1 PROTEASE WITH A SUBSTRATE ANALOG TITLE 2 P6-PR COMPND MOL_ID: 1; COMPND 2 MOLECULE: POL POLYPROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: HIV-1 PROTEASE (RETROPEPSIN); COMPND 5 SYNONYM: RETROPEPSIN; COMPND 6 EC: 3.4.23.16; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: PEPTIDE INHIBITOR; COMPND 11 CHAIN: C; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (BH5 SOURCE 3 ISOLATE); SOURCE 4 ORGANISM_TAXID: 11682; SOURCE 5 STRAIN: BH5 ISOLATE; SOURCE 6 GENE: POL; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET11A; SOURCE 12 MOL_ID: 2; SOURCE 13 SYNTHETIC: YES; SOURCE 14 OTHER_DETAILS: THIS SEQUENCE WAS CHEMICALLY SYNTHESIZED AND IS SOURCE 15 ANALOGOUS TO THE P6-PR PROCESSING SITE IN HIV-1. KEYWDS HIV-1 PROTEASE, MUTANT, DIMER, SUBSTRATE ANALOG, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.TIE,P.I.BOROSS,Y.F.WANG,L.GADDIS,F.LIU,X.CHEN,J.TOZSER, AUTHOR 2 R.W.HARRISON,I.T.WEBER REVDAT 6 23-AUG-23 2AOJ 1 REMARK REVDAT 5 20-OCT-21 2AOJ 1 REMARK SEQADV LINK REVDAT 4 11-OCT-17 2AOJ 1 REMARK REVDAT 3 13-JUL-11 2AOJ 1 VERSN REVDAT 2 24-FEB-09 2AOJ 1 VERSN REVDAT 1 17-JAN-06 2AOJ 0 JRNL AUTH Y.TIE,P.I.BOROSS,Y.F.WANG,L.GADDIS,F.LIU,X.CHEN,J.TOZSER, JRNL AUTH 2 R.W.HARRISON,I.T.WEBER JRNL TITL MOLECULAR BASIS FOR SUBSTRATE RECOGNITION AND DRUG JRNL TITL 2 RESISTANCE FROM 1.1 TO 1.6 ANGSTROMS RESOLUTION CRYSTAL JRNL TITL 3 STRUCTURES OF HIV-1 PROTEASE MUTANTS WITH SUBSTRATE ANALOGS. JRNL REF FEBS J. V. 272 5265 2005 JRNL REFN ISSN 1742-464X JRNL PMID 16218957 JRNL DOI 10.1111/J.1742-4658.2005.04923.X REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.152 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.148 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1596 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 32005 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.142 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.138 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1394 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 28067 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1596 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 155 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 1738.2 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 45 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 18116 REMARK 3 NUMBER OF RESTRAINTS : 24218 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 ANGLE DISTANCES (A) : 0.029 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.034 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.050 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.063 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.011 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.003 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.062 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.091 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ANISOTROPIC REFINEMENT REDUCED FREE R REMARK 3 (NO CUTOFF) BY ? REMARK 4 REMARK 4 2AOJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-DEC-05. REMARK 100 THE DEPOSITION ID IS D_1000034133. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JUL-03 REMARK 200 TEMPERATURE (KELVIN) : 90.0 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99997 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.09100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.41300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1DAZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.64 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE 27%, DMSO 7%,SODIUM REMARK 280 ACETATE BUFFER, PH 5.0, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 29.72250 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.49950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.72250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.49950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9680 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 8 NE - CZ - NH1 ANGL. DEV. = -3.6 DEGREES REMARK 500 ARG A 41 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 ARG A 57 CD - NE - CZ ANGL. DEV. = 13.3 DEGREES REMARK 500 ARG A 57 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG B 157 NE - CZ - NH2 ANGL. DEV. = 3.6 DEGREES REMARK 500 SER C 302 C - N - CA ANGL. DEV. = 25.9 DEGREES REMARK 500 ALA C 310 C - N - CA ANGL. DEV. = 15.2 DEGREES REMARK 500 ALA C 310 O - C - N ANGL. DEV. = 10.0 DEGREES REMARK 500 ALA C 311 C - N - CA ANGL. DEV. = 27.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER C 302 108.52 55.67 REMARK 500 FRD C 305 74.24 -113.61 REMARK 500 FRD C 305 75.86 -108.89 REMARK 500 ALA C 310 -129.04 93.56 REMARK 500 ALA C 310 62.43 62.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 FRD C 305 PRO C 306 140.01 REMARK 500 FRD C 305 PRO C 306 146.62 REMARK 500 THR C 309 ALA C 310 147.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS A 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACY A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACY A 802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACY A 803 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACY A 804 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 805 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF PEPTIDE INHIBITOR REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2AOC RELATED DB: PDB REMARK 900 RELATED ID: 2AOD RELATED DB: PDB REMARK 900 RELATED ID: 2AOE RELATED DB: PDB REMARK 900 RELATED ID: 2AOF RELATED DB: PDB REMARK 900 RELATED ID: 2AOG RELATED DB: PDB REMARK 900 RELATED ID: 2AOH RELATED DB: PDB REMARK 900 RELATED ID: 2AOI RELATED DB: PDB DBREF 2AOJ A 1 99 UNP P04587 POL_HV1B5 69 167 DBREF 2AOJ B 101 199 UNP P04587 POL_HV1B5 69 167 DBREF 2AOJ C 301 312 PDB 2AOJ 2AOJ 301 312 SEQADV 2AOJ LYS A 7 UNP P04587 GLN 75 ENGINEERED MUTATION SEQADV 2AOJ ILE A 33 UNP P04587 LEU 101 ENGINEERED MUTATION SEQADV 2AOJ ILE A 63 UNP P04587 LEU 131 ENGINEERED MUTATION SEQADV 2AOJ ALA A 67 UNP P04587 CYS 135 ENGINEERED MUTATION SEQADV 2AOJ ALA A 95 UNP P04587 CYS 163 ENGINEERED MUTATION SEQADV 2AOJ LYS B 107 UNP P04587 GLN 75 ENGINEERED MUTATION SEQADV 2AOJ ILE B 133 UNP P04587 LEU 101 ENGINEERED MUTATION SEQADV 2AOJ ILE B 163 UNP P04587 LEU 131 ENGINEERED MUTATION SEQADV 2AOJ ALA B 167 UNP P04587 CYS 135 ENGINEERED MUTATION SEQADV 2AOJ ALA B 195 UNP P04587 CYS 163 ENGINEERED MUTATION SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 A 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 A 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 A 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 A 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 A 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 B 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO SEQRES 4 B 99 GLY ARG TRP LYS PRO LYS MET ILE GLY GLY ILE GLY GLY SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU SEQRES 6 B 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 B 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 B 99 GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 C 12 VAL SER PHE ASN FRD PRO GLN ILE THR ALA ALA NH2 HET FRD C 305 20 HET NH2 C 312 2 HET DMS A 701 4 HET DMS A 702 4 HET ACY A 801 4 HET ACY A 802 4 HET ACY A 803 4 HET ACY A 804 4 HET GOL B 805 6 HETNAM FRD 1-PHENYL-2-AMINOPROPANE HETNAM NH2 AMINO GROUP HETNAM DMS DIMETHYL SULFOXIDE HETNAM ACY ACETIC ACID HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 FRD C9 H13 N FORMUL 3 NH2 H2 N FORMUL 4 DMS 2(C2 H6 O S) FORMUL 6 ACY 4(C2 H4 O2) FORMUL 10 GOL C3 H8 O3 FORMUL 11 HOH *155(H2 O) HELIX 1 1 GLY A 86 THR A 91 1 6 HELIX 2 2 GLN A 92 GLY A 94 5 3 HELIX 3 3 GLY B 186 THR B 191 1 6 SHEET 1 A 4 GLN A 2 ILE A 3 0 SHEET 2 A 4 THR B 196 ASN B 198 -1 O LEU B 197 N ILE A 3 SHEET 3 A 4 THR A 96 ASN A 98 -1 N ASN A 98 O THR B 196 SHEET 4 A 4 GLN B 102 ILE B 103 -1 O ILE B 103 N LEU A 97 SHEET 1 B 8 TRP A 42 GLY A 49 0 SHEET 2 B 8 GLY A 52 ILE A 66 -1 O GLN A 58 N LYS A 43 SHEET 3 B 8 HIS A 69 VAL A 77 -1 O HIS A 69 N ILE A 66 SHEET 4 B 8 VAL A 32 ILE A 33 1 N ILE A 33 O LEU A 76 SHEET 5 B 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32 SHEET 6 B 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85 SHEET 7 B 8 LEU A 10 ILE A 15 -1 N ILE A 13 O LYS A 20 SHEET 8 B 8 GLY A 52 ILE A 66 -1 O GLU A 65 N LYS A 14 SHEET 1 C 9 GLN C 307 THR C 309 0 SHEET 2 C 9 LYS B 143 GLY B 149 -1 N GLY B 148 O ILE C 308 SHEET 3 C 9 GLY B 152 ILE B 166 -1 O GLN B 158 N LYS B 143 SHEET 4 C 9 HIS B 169 VAL B 177 -1 O HIS B 169 N ILE B 166 SHEET 5 C 9 VAL B 132 ILE B 133 1 N ILE B 133 O LEU B 176 SHEET 6 C 9 ILE B 184 ILE B 185 -1 O ILE B 184 N VAL B 132 SHEET 7 C 9 GLN B 118 LEU B 124 1 N LEU B 123 O ILE B 185 SHEET 8 C 9 LEU B 110 ILE B 115 -1 N ILE B 113 O LYS B 120 SHEET 9 C 9 GLY B 152 ILE B 166 -1 O GLU B 165 N LYS B 114 LINK C AASN C 304 N AFRD C 305 1555 1555 1.32 LINK C BASN C 304 N BFRD C 305 1555 1555 1.33 LINK C AFRD C 305 N APRO C 306 1555 1555 1.34 LINK C BFRD C 305 N BPRO C 306 1555 1555 1.33 LINK C AALA C 311 N ANH2 C 312 1555 1555 1.25 LINK C BALA C 311 N BNH2 C 312 1555 1555 1.25 CISPEP 1 VAL C 301 SER C 302 0 25.44 CISPEP 2 THR C 309 ALA C 310 0 12.95 SITE 1 AC1 5 TRP A 6 ARG B 187 ASN B 188 HOH B1063 SITE 2 AC1 5 HOH B1070 SITE 1 AC2 3 LYS A 70 HOH A1085 HOH B1059 SITE 1 AC3 2 HOH A1149 GOL B 805 SITE 1 AC4 3 MET A 46 LYS A 55 HOH A1137 SITE 1 AC5 2 LYS A 43 GLN A 58 SITE 1 AC6 1 ARG A 41 SITE 1 AC7 6 ACY A 801 LYS B 155 VAL B 156 ARG B 157 SITE 2 AC7 6 HOH B1067 HOH B1112 SITE 1 AC8 41 TRP A 6 ARG A 8 ASP A 25 GLY A 27 SITE 2 AC8 41 ALA A 28 ASP A 29 ASP A 30 LYS A 45 SITE 3 AC8 41 MET A 46 ILE A 47 GLY A 48 GLY A 49 SITE 4 AC8 41 ILE A 50 PHE A 53 PRO A 81 VAL A 82 SITE 5 AC8 41 ILE A 84 ARG B 108 LEU B 123 ASP B 125 SITE 6 AC8 41 GLY B 127 ALA B 128 ASP B 129 ASP B 130 SITE 7 AC8 41 LYS B 145 MET B 146 ILE B 147 GLY B 148 SITE 8 AC8 41 GLY B 149 ILE B 150 PHE B 153 GLN B 161 SITE 9 AC8 41 ILE B 172 PRO B 181 VAL B 182 ILE B 184 SITE 10 AC8 41 GLN B 192 HOH B1008 HOH B1018 HOH B1135 SITE 11 AC8 41 HOH C1013 CRYST1 59.445 86.999 46.317 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016822 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011494 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021590 0.00000